介入栓塞治疗微小前交通动脉瘤的临床疗效分析  

Clinical Analysis of Interventional Embolization in the Treatment of Small Anterior Communicating Artery Aneurysms

作　　者：龚勇 樊天禹 张帅[1] 邓一平 黄云峰 向鹏 GONG Yong;FAN Tian-yu;ZHANG Shuai(Neurosurgery Department,Changsha Central Hospital Affiliated to Nanhua University,Changsha,Hunan,PR China.410000)

机构地区：[1]南华大学附属长沙中心医院神经外科,湖南长沙410000

出　　处：《医学临床研究》2020年第8期1188-1191,共4页Journal of Clinical Research

摘　　要：【目的】探讨介入栓塞治疗微小前交通动脉瘤患者的临床疗效。【方法】收集长沙市中心医院神经外科2011年1月至2017年6月共计28例微小前交通动脉瘤采用介入栓塞治疗患者的临床资料,分析其治疗过程,术后6个月采用改良的Rankin量表评分评估其预后,评分≤2分认为预后良好。【结果】28例患者中死亡2例、预后不良总计8例,预后良好20例,无植物生存患者。术后6个月共有21例患者行DSA复查均显示载瘤动脉通畅,支架内无明显狭窄;2例动脉瘤出现复发,均为单纯弹簧圈栓塞患者。7例患者未能行DSA复查,其中包括2例死亡患者,另外5例患者行电话随访。【结论】采用介入栓塞治疗微小前交通动脉瘤,近期疗效确切,患者预后较好,值得临床借鉴。【Objective】To investigate the clinical effect of interventional embolization in the treatment of small anterior communicating artery aneurysm.【Methods】The clinical data of 28 patients with small anterior communicating artery aneurysms treated by interventional embolization in the Department of Neurosurgery of Changsha Central Hospital from January 2011 to June 2017 were collected,and the treatment process was analyzed.The prognosis was evaluated by improved Rankin Scale score 6 months after operation,and the prognosis was considered as good if the score was less than or equal to 2.【Results】Among the 28 cases,2 cases died,8 cases had poor prognosis,20 cases had good prognosis and no plant survival patients.Six months after operation,21 patients underwent DSA reexamination,all showed that the parent artery was unobstructed,and no obvious stenosis was found in the stent;2 cases of aneurysm recurrence,all of them were patients with simple coil embolization.Seven patients failed to undergo DSA reexamination,including 2 dead patients,and 5 patients were followed up by telephone.【Conclusion】Interventional embolization for the treatment of small anterior communicating artery aneurysms has good short-term effect and good prognosis,which is worthy of clinical reference.

关 键 词：动脉瘤/外科学 栓塞 治疗性 

分 类 号：R654.3[医药卫生—外科学]